Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PEL, a 'new' high-frequency red cell surface antigen

G L Daniels1, H Simard, M Goldman

  • 1MRC Blood Group Unit, London, UK.

Vox Sanguinis
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of one or two successive annual applications of organic fertilisers on the enzyme activity of a soil under barley cultivation.

Bioresource technology·2001
Same author

Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.

Journal of molecular biology·2001
Same author

Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.

International journal of antimicrobial agents·2001
Same author

Serum leptin levels in cattle with different nutritional conditions.

Nutrition research (New York, N.Y.)·2001
Same author

A web page to teach neurology and neuropathology to medical students.

Neuropathology and applied neurobiology·2001
Same author

Constituents of Coriaria ruscifolia fruits.

Fitoterapia·2001
Same journal

Barriers and enablers to non-remunerated plasma donation: A meta-synthesis of the qualitative literature using the theoretical domains framework.

Vox sanguinis·2026
Same journal

Haemolytic disease of the foetus and newborn due to anti-M: A systematic review.

Vox sanguinis·2026
Same journal

In vitro evaluation of apheresis platelet and plasma products collected and stored in non-DEHP disposable sets.

Vox sanguinis·2026
Same journal

Survey of national and regional rare donor programmes regarding Immunoglobulin A deficiency.

Vox sanguinis·2026
Same journal

Fibrinogen recovery in cryoprecipitate prepared from thawed plasma stored for 5 days post-thaw.

Vox sanguinis·2026
Same journal

Abstracts of the 39th International Congress of the ISBT, Kuala Lumpur, Malaysia, 20-24 June 2026.

Vox sanguinis·2026
See all related articles

A new inherited blood group antigen, PEL (901014), has been identified. Two individuals with anti-PEL antibodies and two with weak PEL expression were found in French-Canadian populations.

Area of Science:

  • * Hematology
  • * Immunology
  • * Genetics

Background:

  • * Blood group antigens are crucial for transfusion compatibility and understanding inherited traits.
  • * The discovery of new antigens expands our knowledge of human blood group systems.
  • * Genetic factors influence the expression and immunogenicity of blood group antigens.

Observation:

  • * A novel, high-frequency inherited blood group antigen, designated PEL (901014), has been identified.
  • * Two French-Canadian individuals were found to possess antibodies against the PEL antigen (anti-PEL).
  • * Two additional French-Canadian individuals exhibited weak PEL expression on their red blood cells and produced an antibody (anti-MTP) that did not react with PEL-positive cells.

Findings:

  • * The PEL antigen is inherited and appears to be of high frequency within the studied population.

Related Experiment Videos

  • * The presence of anti-PEL antibodies suggests PEL is immunogenic in certain individuals.
  • * The distinct antibody (anti-MTP) observed in individuals with weak PEL expression indicates a potential related but separate antigen or epitope.
  • Implications:

    • * The identification of the PEL antigen necessitates its inclusion in blood group typing protocols.
    • * Understanding PEL antigen expression and potential alloimmunization is critical for transfusion medicine, particularly in populations with a high frequency of the antigen.
    • * Further research is needed to fully characterize the PEL antigen, its genetic basis, and the nature of the anti-MTP antibody.